Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation ...
Structure Therapeutics (GPCR) announced positive topline data from the ACCESS clinical program of aleniglipron for the treatment of people living ...
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...
Investing.com -- Structure Therapeutics Inc ADR (NASDAQ:GPCR) stock soared 28.8% in premarket trading Monday after the company announced positive topline data from its ACCESS clinical program for ...
Long the titan of prep schools in Los Angeles, with a reputation as an Ivy League feeder, Harvard-Westlake has seen the ...
The Vicksburg Police Department officially launched its new U-Turn youth diversion program this week, drawing what Deputy ...
The MARK Passenger Rail Commission held its inaugural meeting on December 5, 2025, at Racine City Hall, where members adopted ...
This edition of the NCAA 2025-26 women's college basketball season's power rankings covers expected dominance and unexpected ...
Before diving into program rankings and university brochures, the most crucial step is to know yourself. Why are you pursuing a BBA? Are you looking to gain a foundational understanding of business, ...
M-tron shows strong backlog, major defense and space programs, margin progress and undervaluation with expanding revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback